[1]
P. Skalij, P. Tokajuk, and M. Z. Wojtukiewicz, “TAS-102 – a new option in the treatment of patients with advanced colorectal cancer after failure or intolerance to other therapies”, OncoReview, vol. 10, no. 1(37), pp. 8-14, Mar. 2020.